Cancer Immunotherapy Market Size, Trends, Growth & Outlook

Cancer Immunotherapy Market - By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines, Cancer Vaccines, Others), By Therapeutic Area (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Others), By End User (Hospitals, Cancer Research Institutes, ASC's, Clinics) & Global Region - Market Size, Trends, Opportunity, Forecast 2019-2027

Industry: Life Science | Report ID: FAMI-00727 | Published on: Jan, 2020 | View: 957 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

This study aims to provide a detailed analysis of the global cancer immunotherapy market along with qualitative trends for the year 2019. Further, the report also offers future trends and market forecast upto 2027.

The study includes the cancer immunotherapy market size and forecast for the global cancer immunotherapy market through 2027, segmented by therapy type, therapeutic area, end user and Region type as follows:

Cancer Immunotherapy Market, By Therapy Type:

• Monoclonal Antibodies
• Immune Checkpoint Inhibitors
o PD-1/PD-L1
o CTLA-4
• Cancer Vaccines
• Immune System Modulators
• Others

Cancer Immunotherapy Market, By Therapeutic Area:

• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Melanoma
• Blood Cancers
• Others

Cancer Immunotherapy Market, By End User:
• Hospitals
• ASC's
• Cancer Research Institutes
• Clinics

An in-depth analysis of the regional market scenario of the industry offers detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) along with the coverage of major countries in each region.

Cancer Immunotherapy Market, By Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global cancer immunotherapy market size has been derived using both primary interviews and secondary research. The research process starts with exhaustive secondary research using internal and external sources to obtain various qualitative and quantitative market insights related to the cancer immunotherapy market. Also, multiple primary interviews were conducted with industry experts in order to validate data and analysis. Primary interview sources include industry expert such as VPs, Marketing Directors business development managers, market intelligence managers, and country sales managers, and key opinion leaders specializing in the cancer immunotherapy market.

Some of the features of “Cancer Immunotherapy Market Report: Market Size, Trends, Opportunity, Forecast 2019-2027” include:

Market Size: Global cancer immunotherapy market size estimation in terms of value (USD Million)

Forecast Analysis: Market forecast (2019-2027) by application and end user

Segmentation Analysis: Global cancer immunotherapy market value by various segments such as therapy type, therapeutic area in terms of value

Regional Analysis: Global cancer immunotherapy market split by North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Growth Opportunities: Analysis on growth opportunities in different segments and regions of cancer immunotherapy market

Strategic Analysis: This section offers insights on merger and acquisition activities, new product development, and competitive landscape of cancer immunotherapy in the global cancer immunotherapy market
Analysis of competitive intensity of the industry on the basis of Porter’s Five Forces model

Key Questions Answered in this Report:

What are the most promising and high-growth trends in the global cancer immunotherapy market?

What are the key factors impacting market dynamics? What are the growth drivers, and restraints in cancer immunotherapy market?

What are the emerging industry trends in cancer immunotherapy market?

What are recent developments in the cancer immunotherapy market? Which companies are leading these industry activities?

What merger & acquisition activities have occurred in the past3 years and what is its impact on the cancer immunotherapy industry?

Get a sample pages of this report Click here

Research Methodology

Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Cancer Immunotherapy Market
3. Global Cancer Immunotherapy Market Trends
4. Opportunities in Global Cancer Immunotherapy Market
5. Recent Industry Activities, 2019
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Cancer Immunotherapy Market Size (USD Million), Growth Analysis and Forecast, (2019 - 2027)

9. Global Cancer Immunotherapy Market Segmentation Analysis, By Therapy Type
9.1. Introduction
9.2. Market Attractiveness, By Therapy Type
9.3. BPS Analysis, By Therapy Type
9.4. Monoclonal Antibodies
9.5. Immune Checkpoint Inhibitors
9.5.1. PD-1/PD-L1
9.5.2. CTLA-4
9.6. Cancer Vaccines
9.7. Immune System Modulators
9.8. Others

10. Global Cancer Immunotherapy Market Segmentation Analysis, By Therapeutic Area
10.1. Introduction
10.2. Market Attractiveness, By Therapeutic Area
10.3. BPS Analysis, By Therapeutic Area
10.4. Lung Cancer
10.5. Colorectal Cancer
10.6. Breast Cancer
10.7. Prostate Cancer
10.8. Melanoma
10.9. Blood Cancers
10.10. Others

11. Global Cancer Immunotherapy Market Segmentation Analysis, By End User
11.1. Introduction
11.2. Market Attractiveness, By End User
11.3. BPS Analysis, By End User
11.4. Oral
11.5. Parenteral
11.6. Topical

12. Geographical Analysis
12.1. Introduction
12.2. North America Cancer Immunotherapy Market Size (USD Million), 2019 - 2027
12.2.1. By Therapy Type
12.2.2. By Therapeutic Area
12.2.3. By End User
12.2.4. By Country
12.2.4.1. Market Attractiveness, By End-user
12.2.4.2. BPS Analysis, By End-User
12.2.4.3. U.S. Market Size (USD Million), 2019 - 2027
12.2.4.4. Canada Market Size (USD Million), 2019 - 2027

12.3. Europe Cancer Immunotherapy Market Size (USD Million), 2019 - 2027
12.3.1. By Therapy Type
12.3.2. By Therapeutic Area
12.3.3. By End User
12.3.4. By Country
12.3.4.1. Market Attractiveness, By Country
12.3.4.2. BPS Analysis, By Country
12.3.4.3. Germany Market Size (USD Million), 2019 - 2027
12.3.4.4. United Kingdom Market Size (USD Million), 2019 - 2027
12.3.4.5. France Market Size (USD Million), 2019 - 2027
12.3.4.6. Italy Market Size (USD Million), 2019 - 2027
12.3.4.7. Spain Market Size (USD Million), 2019 - 2027
12.3.4.8. Russia Market Size (USD Million), 2019 - 2027
12.3.4.9. Rest of Europe Market Size (USD Million), 2019 - 2027

12.4. Asia Pacific Cancer Immunotherapy Market Size (USD Million), 2019 - 2027
12.4.1. By Therapy Type
12.4.2. By Therapeutic Area
12.4.3. By End User
12.4.4. By Country
12.4.4.1. Market Attractiveness, By Country
12.4.4.2. BPS Analysis, By Country
12.4.4.3. China Market Size (USD Million), 2019 - 2027
12.4.4.4. India Market Size (USD Million), 2019 - 2027
12.4.4.5. Japan Market Size (USD Million), 2019 - 2027
12.4.4.6. South Korea Market Size (USD Million), 2019 - 2027
12.4.4.7. Indonesia Market Size (USD Million), 2019 - 2027
12.4.4.8. Taiwan Market Size (USD Million), 2019 - 2027
12.4.4.9. Australia Market Size (USD Million), 2019 - 2027
12.4.4.10. New Zealand Market Size (USD Million), 2019 - 2027
12.4.4.11. Rest of Asia Pacific Market Size (USD Million), 2019 - 2027

12.5. Latin America Cancer Immunotherapy Market Size (USD Million), 2019 - 2027
12.5.1. By Therapy Type
12.5.2. By Therapeutic Area
12.5.3. By End User
12.5.4. By Country
12.5.4.1. Market Attractiveness, By Country
12.5.4.2. BPS Analysis, By Country
12.5.4.3. Brazil Market Size (USD Million), 2019 - 2027
12.5.4.4. Mexico Market Size (USD Million), 2019 - 2027
12.5.4.5. Rest of Latin America Market Size (USD Million), 2019 - 2027

12.6. Middle East & Africa Cancer Immunotherapy Market Size (USD Million), 2019 - 2027
12.6.1. By Therapy Type
12.6.2. By Therapeutic Area
12.6.3. By End User
12.6.4. By Country
12.6.4.1. Market Attractiveness, By Geography
12.6.4.2. BPS Analysis, By Geography
12.6.4.3. GCC Market Size (USD Million), 2019 - 2027
12.6.4.4. North Africa Market Size (USD Million), 2019 - 2027
12.6.4.5. South Africa Market Size (USD Million), 2019 - 2027
12.6.4.6. Rest of Middle East & Africa Market Size (USD Million), 2019 - 2027

13. Competitive Landscape
13.1. AstraZenca Plc
13.2. Bristol-Myers Squibb Company
13.3. Amgen
13.4. Eli Lilly and Company
13.5. F.Hoffmann-La Roche Ltd
13.6. Janssen Biotech
13.7. GlaxoSmithKline Plc
13.8. Merck & Co
13.9. Novartis AG
13.10. Sanofi

Select License Type
  • Single User License $3840 USD
  • Multi-User License $5370 USD
  • Corporate User License $6450 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.